2026-526411-11-00暂停1 期
A Safety Study to Test a New Medicine (ANT3310) Alone and When Taken with an Antibiotic (Meropenem) in Healthy Adult Participants.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 暂停
- 发起方
- Antabio
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Christian Zwingelstein
Scientific
Antabio
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A Phase 1 Study to Determine the Safety, and Pharmacokinetics of the Selective MET kinase Inhibitor, DO-2 in Patients With Advanced or Refractory Solid Tumours2023-504897-39-00Deuteroncology, Deuteroncology60
招募中
不适用
A study to test how well different doses of BI 3820768 are tolerated by people with advanced cancer (solid tumours)Germ Cell Tumour, Endometrial Cancer and Ovarian CancerjRCT2031260005187
招募中
1 期
Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetics of intravenous single ascending doses of IM-250 in healthy volunteers.Herpes simplex virus encephalitis2025-523146-27-00Innovative Molecules GmbH30
招募中
1 期
Clinical study to test the safety, tolerance and preliminary efficacy of oral ITF3756 administered alone or in combination with an anti-protein 4 agent associated with cytotoxic T lymphocytes in patients with advanced solid tumors.2022-501089-22-00Italfarmaco S.p.A.60
招募中
1 期
Phase I clinical trial evaluating the safety, tolerability, and absorption of a topical product containing latanoprost acid in healthy participants.Androgenetic alopecia2025-522468-34-00Bioresearch Pharma S.A.24